Merck - Asia Tech Wire

Merck

2025.02.05

12:01

Merck to suspend supply of HPV vaccine Gardasil to China

Merck, known as Merck Sharp & Dohme (MSD) outside the U.S. and Canada, announced Tuesday that it is suspending supplies of the HPV vaccine Gardasil to China, a suspension that is expected to last at least until mid-year.

2024.12.23

17:44

Merck to invest more than $72.88 million in new advanced materials development center in Japan

German pharmaceutical giant Merck announced last week that it will invest more than 70 million euros ($72.88 million) to build a new advanced materials development center at its Shizuoka plant in Japan.

2024.12.20

16:22

Merck to acquire Dutch organoid company HUB

German drugmaker Merck announced this week that it has now signed a definitive agreement for the planned acquisition of Dutch organoid company HUB Organoids Holding B.V. (HUB).

2022.03.21

06:30

S. Korea to introduce Merck's COVID-19 pill for 100,000 patients

Asian Tech Press (Mar. 21) -- South Korea will introduce Merck's COVID-19 pill molnupiravir, which is under the brand name Lagevrio, for 100,000 patients this week.

2022.01.20

15:30

China's Fosun Pharma to produce low-cost versions of Merck's COVID-19 pill

Asian Tech Press (Jan 20) -- BioNTech partner Fosun Pharma has been licensed by a UN-backed agency to produce and supply low-cost versions of Merck's COVID-19 pill molnupiravir to low- and middle-income countries.

12:19

Three S.Korean firms picked by UN-backed agency to produce Merck's COVID-19 pill

Asian Tech Press (Jan 20) -- Three South Korean drugmakers have been selected by a UN-backed agency to produce low-cost versions of Merck's COVID-19 pill molnupiravir, Yonhap News Agency reported Thursday.

2022.01.11

10:36

Merck says to increase HPV vaccine supply to China in 2022

Asian Tech Press (Jan 11) -- Biopharmaceutical company Merck said its HPV vaccine supply to China is growing year by year and will increase significantly in 2022.

2022.01.06

10:51

Indian medical agency says Merck's COVID-19 pill has major safety concerns

Asian Tech Press (Jan 6) -- The head of India's top medical research agency said Wednesday that Merck's COVID-19 pill molnupiravir has major safety concerns.

2021.12.03

08:32

Merck files marketing application for COVID-19 pill in Japan

Asian Tech Press (Dec 3) -- U.S. drug company Merck Sharp & Dohme Corp. (MSD) has reportedly filed an application to market its COVID-19 pill molnupiravir in Japan.

2021.11.11

09:13

South Korea to import Covid-19 pill from February 2022

Asian Tech Press (Nov 11) -- According to Yonhap News Agency, the Covid antiviral pill purchased by the South Korean government will be delivered from February next year.

2021.11.10

14:13

Japan to spend $1.2 billion for 1.6 million courses of Merck's COVID-19 pill

Asian Tech Press (Nov 10) -- The Japanese government will reportedly spend nearly $1.2 billion for 1.6 million courses of Merck's COVID-19 pill.

2021.11.08

09:42

S. Korea in talks with Merck, Pfizer, Roche to buy 134,000 courses of COVID-19 pill

Asian Tech Press (Nov 8) -- The South Korean government is reportedly negotiating with US-based Merck & Co., Inc., Pfizer Inc., and Switzerland's Roche Holding AG for the procurement of an additional 134,000 courses of COVID-19 pill.

Email Subscription

Newsletters and emails are now available! Delivered on time, every weekday, to keep you up to date with North American business news.

Weekly Highlights

                                    Southwest Airlines CEO: Although Boeing still has a lot of work to do, they seem to be moving in a good direction and we are more optimistic.
                            2025-01-31

                                    White House Press Secretary Levitt: Details about the Nvidia meeting are still unclear.
                            2025-02-01

                                    Apple (AAPL.O) said the Apple Pay outage has been resolved.
                            2025-01-29

                                    Jefferies: Raised Meta Platforms (META.O) price target from $715 to $810.
                            2025-01-30

                                    Sam Altman, founder and CEO of OpenAI: OpenAI will develop specialized hardware for AI.
                            2025-02-03